MicroRNAs (miRNAs) -- the discovery of which received the Nobel Prize in Physiology or Medicine last year -- may play a significant role in the treatment and cure of Alzheimer's Disease (AD), said researchers from Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR). 

Alzheimer's Disease is a devastating condition that steals away mental faculties and debilitates day-to-day life of patients. Characterised by the accumulation of protein clumps in the brain, memory loss, and cognitive deficits, it is estimated to affect more than 57.4 million people worldwide, a number that is expected to almost triple to 152.8 million cases by 2050.

Addressing this, researchers from JNCASR, an autonomous institute of the Department of Science and Technology (DST), explored altered miRNAs in the Alzheimer's brain for early, specific, and accurate clinical diagnosis of the condition.